CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-01 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +28,689 | $11.29 | $324K | 151,489 |
| 2021-04-01 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −9,695 | $42.11 | $408K | 141,794 |
| 2021-04-01 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −18,994 | $42.79 | $813K | 122,800 |
| 2021-04-01 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Option to Purchase Common Stock | −28,689 | 11,311 | ||
| 2021-04-01 | Sun Elaine D SVP, Chief Financial Officer | Exercise or conversion | +10,196 | 18,077 | ||
| 2021-04-01 | Sun Elaine D SVP, Chief Financial Officer | Shares withheld for taxes | −4,059 | $42.43 | $172K | 14,018 |
| 2021-04-01 | Sun Elaine D SVP, Chief Financial Officer | Exercise or conversion · Performance Stock Units | −10,196 | 30,600 | ||
| 2021-03-02 | Sun Elaine D SVP, Chief Financial Officer | Exercise or conversion | +12,166 | 12,166 | ||
| 2021-03-02 | Sun Elaine D SVP, Chief Financial Officer | Shares withheld for taxes | −4,285 | $45.01 | $193K | 7,881 |
| 2021-03-02 | Sun Elaine D SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −12,166 | 36,496 | ||
| 2021-03-01 | Kelley Kenneth J Director | Sale | −4,500 | $45.26 | $204K | 185,333 |
| 2021-03-01 | Kelley Kenneth J Director | Sale | −500 | $46.08 | $23K | 184,833 |
| 2021-03-01 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −11,794 | $45.56 | $537K | 129,330 |
| 2021-03-01 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −6,530 | $46.26 | $302K | 122,800 |
| 2021-03-01 | Torley Helen President and CEO | Exercise or conversion | +50,000 | $14.66 | $733K | 587,160 |
| 2021-03-01 | Torley Helen President and CEO | Sale | −16,110 | $45.58 | $734K | 571,050 |
| 2021-03-01 | Torley Helen President and CEO | Sale | −33,890 | $46.48 | $1.6M | 537,160 |
| 2021-03-01 | Torley Helen President and CEO | Exercise or conversion · Option to Purchase Common Stock | −50,000 | $14.66 | $733K | 550,000 |
| 2021-02-22 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +8,803 | 145,488 | ||
| 2021-02-22 | LaBarre Michael J. SVP, Chief Technical Officer | Shares withheld for taxes | −4,364 | $48.69 | $212K | 141,124 |
Page 51 of 59 · 1,177 trades